Compare PFAI & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PFAI | POM |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | Canada | China |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Other Specialty Stores |
| Sector | Consumer Staples | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.1M | 30.3M |
| IPO Year | 2025 | 2025 |
| Metric | PFAI | POM |
|---|---|---|
| Price | $2.23 | $0.24 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 19.0K | ★ 476.3K |
| Earning Date | 02-27-2026 | 12-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $3,497,672.00 | ★ $51,210,721.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 28.80 | 12.13 |
| 52 Week Low | $1.30 | $0.21 |
| 52 Week High | $4.93 | $6.43 |
| Indicator | PFAI | POM |
|---|---|---|
| Relative Strength Index (RSI) | 50.39 | 29.85 |
| Support Level | $2.16 | $0.22 |
| Resistance Level | $2.38 | $0.27 |
| Average True Range (ATR) | 0.18 | 0.02 |
| MACD | 0.00 | 0.06 |
| Stochastic Oscillator | 30.43 | 57.34 |
Pinnacle Food Group Ltd is a provider of smart farming solutions focused on vertical and hydroponic farming. The company focuses on promoting sustainable food security by developing and building customized smart farming systems for customers based on the systematic integration of technology, hardware, and software, coupled with a full range of integrated supply and technical services. It sells hydroponic growing systems and technical support services to individual households and community groups, and is developing a hydroponic growing system for urban farms. Geographically, the company generates the majority revenue from Canada, followed by New Zealand.
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.